Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T McInnes

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
ACS Synthetic Biology|June 7, 2022
Discovering Content through Text Mining for a Synthetic Biology Knowledge SystemBridget T McInnes, J Stephen Downie, Yikai Hao, et al.
Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.
Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Journal of Human Hypertension|November 1, 2001
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocolP S Sever, B Dahlöf, N R Poulter, et al.
Lancet (London, England)|June 23, 2004
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialStevo Julius, Sverre E Kjeldsen, Michael Weber, et al.
Hypertension (Dallas, Tex. : 1979)|May 8, 2013
Blood pressure response to patterns of weather fluctuations and effect on mortalityLouise Aubinière-Robb, Panniyammakal Jeemon, Claire E Hastie, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Journal of Hypertension|October 16, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetesJan Ostergren, Neil R Poulter, Peter S Sever, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
ACS Synthetic Biology|June 7, 2022
Discovering Content through Text Mining for a Synthetic Biology Knowledge SystemBridget T McInnes, J Stephen Downie, Yikai Hao, et al.
Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.
Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Journal of Human Hypertension|November 1, 2001
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocolP S Sever, B Dahlöf, N R Poulter, et al.
Lancet (London, England)|June 23, 2004
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialStevo Julius, Sverre E Kjeldsen, Michael Weber, et al.
Hypertension (Dallas, Tex. : 1979)|May 8, 2013
Blood pressure response to patterns of weather fluctuations and effect on mortalityLouise Aubinière-Robb, Panniyammakal Jeemon, Claire E Hastie, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Journal of Hypertension|October 16, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetesJan Ostergren, Neil R Poulter, Peter S Sever, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Pageof 22